Basic helix-loop-helix (bHLH) transcription factors have been implicated in cell lineage determination and differentiation. The protein encoded by this gene is a bHLH transcription factor and shares similarity with another bHLH transcription factor, Dermo1 (a.k.a. TWIST2). The strongest expression of this mRNA is in placental tissue; in adults, mesodermally derived tissues express this mRNA preferentially.
Twist is activated by a variety of signal transduction pathways, including Akt, signal transducer and activator of transcription 3 (STAT3), mitogen-activated protein kinase, Ras, and Wnt signaling. Activated Twist upregulates N-cadherin and downregulates E-cadherin, which are the hallmarks of EMT. Moreover, Twist plays an important role in some physiological processes involved in metastasis, like angiogenesis, invadopodia, extravasation, and chromosomal instability. Twist also protects cancer cells from apoptotic cell death. In addition, Twist is responsible for the maintenance of cancer stem cells and the development of chemotherapy resistance. Twist1 is extensively studied for its role in head- and neck cancers. Here, Twist1 has been shown to be involved in evading apoptosis, making the tumour cells resistant against chemotherapeutic drugs like cisplatin. Moreover, Twist1 has been shown to be expressed under conditions of hypoxia, corresponding to the observation that hypoxic cells respond less to chemotherapeutic drugs.
Another process in which Twist 1 is involved is tumour metastasis. The underlying mechanism is not completely understood, but it has been implicated in the upregulation of matrix metalloproteinases and inhibition of TIMP.
Recently, targeting Twist has gained interest as a target for cancer therapeutics. The inactivation of Twist by small interfering RNA or chemotherapeutic approach has been demonstrated in vitro. Moreover, several inhibitors which are antagonistic to the upstream or downstream molecules of Twist signaling pathways have also been identified.
^Bourgeois P, Stoetzel C, Bolcato-Bellemin AL, Mattei MG, Perrin-Schmitt F (December 1996). "The human H-twist gene is located at 7p21 and encodes a B-HLH protein that is 96% similar to its murine M-twist counterpart". Mamm. Genome7 (12): 915–7. doi:10.1007/s003359900269. PMID8995765.
^Kress W, Schropp C, Lieb G, Petersen B, Büsse-Ratzka M, Kunz J, Reinhart E, Schäfer WD, Sold J, Hoppe F, Pahnke J, Trusen A, Sörensen N, Krauss J, Collmann H (January 2006). "Saethre-Chotzen syndrome caused by TWIST 1 gene mutations: functional differentiation from Muenke coronal synostosis syndrome". Eur. J. Hum. Genet.14 (1): 39–48. doi:10.1038/sj.ejhg.5201507. PMID16251895.
^Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD, Jabs EW (January 1997). "Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome". Nat. Genet.15 (1): 36–41. doi:10.1038/ng0197-36. PMID8988166.
^ abMartin TA, Goyal A, Watkins G, Jiang WG (June 2005). "Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer". Ann. Surg. Oncol.12 (6): 488–96. doi:10.1245/ASO.2005.04.010. PMID15864483.
^van Doorn R, Dijkman R, Vermeer MH, Out-Luiting JJ, van der Raaij-Helmer EM, Willemze R, Tensen CP (August 2004). "Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis". Cancer Res.64 (16): 5578–86. doi:10.1158/0008-5472.CAN-04-1253. PMID15313894.
^ abWu KJ, Yang MH (December 2011). "Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection". Biosci. Rep.31 (6): 449–55. doi:10.1042/BSR20100114. PMID21919891.
^Zhuo WL, Wang Y, Zhuo XL, Zhang YS, Chen ZT (May 2008). "Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway". Biochem. Biophys. Res. Commun.369 (4): 1098–102. doi:10.1016/j.bbrc.2008.02.143. PMID18331824.
^Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC (March 2011). "Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1". J. Cell. Mol. Med.15 (3): 691–700. doi:10.1111/j.1582-4934.2010.01052.x. PMID20219012.
^Okamura H, Yoshida K, Haneji T (July 2009). "Negative regulation of TIMP1 is mediated by transcription factor TWIST1". Int. J. Oncol.35 (1): 181–6. doi:10.3892/ijo_00000327. PMID19513566.
^ abHamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, Nakatani Y, Kedes L (February 1999). "Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A". Cell96 (3): 405–13. doi:10.1016/S0092-8674(00)80553-X. PMID10025406.
^El Ghouzzi V, Legeai-Mallet L, Aresta S, Benoist C, Munnich A, de Gunzburg J, Bonaventure J (March 2000). "Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location". Hum. Mol. Genet.9 (5): 813–9. doi:10.1093/hmg/9.5.813. PMID10749989.
Rose CS, King AA, Summers D et al. (1995). "Localization of the genetic locus for Saethre-Chotzen syndrome to a 6 cM region of chromosome 7 using four cases with apparently balanced translocations at 7p21.2.". Hum. Mol. Genet.3 (8): 1405–8. doi:10.1093/hmg/3.8.1405. PMID7987323.CS1 maint: Explicit use of et al. (link)
Maw M, Kar B, Biswas J et al. (1997). "Linkage of blepharophimosis syndrome in a large Indian pedigree to chromosome 7p.". Hum. Mol. Genet.5 (12): 2049–54. doi:10.1093/hmg/5.12.2049. PMID8968762.CS1 maint: Explicit use of et al. (link)
el Ghouzzi V, Le Merrer M, Perrin-Schmitt F et al. (1997). "Mutations of the TWIST gene in the Saethre-Chotzen syndrome.". Nat. Genet.15 (1): 42–6. doi:10.1038/ng0197-42. PMID8988167.CS1 maint: Explicit use of et al. (link)
Wang SM, Coljee VW, Pignolo RJ et al. (1997). "Cloning of the human twist gene: its expression is retained in adult mesodermally-derived tissues.". Gene187 (1): 83–92. doi:10.1016/S0378-1119(96)00727-5. PMID9073070.CS1 maint: Explicit use of et al. (link)
Krebs I, Weis I, Hudler M et al. (1997). "Translocation breakpoint maps 5 kb 3' from TWIST in a patient affected with Saethre-Chotzen syndrome.". Hum. Mol. Genet.6 (7): 1079–86. doi:10.1093/hmg/6.7.1079. PMID9215678.CS1 maint: Explicit use of et al. (link)
Rose CS, Patel P, Reardon W et al. (1997). "The TWIST gene, although not disrupted in Saethre-Chotzen patients with apparently balanced translocations of 7p21, is mutated in familial and sporadic cases.". Hum. Mol. Genet.6 (8): 1369–73. doi:10.1093/hmg/6.8.1369. PMID9259286.CS1 maint: Explicit use of et al. (link)
Hamamori Y, Sartorelli V, Ogryzko V et al. (1999). "Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A.". Cell96 (3): 405–13. doi:10.1016/S0092-8674(00)80553-X. PMID10025406.CS1 maint: Explicit use of et al. (link)
El Ghouzzi V, Legeai-Mallet L, Aresta S et al. (2000). "Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location.". Hum. Mol. Genet.9 (5): 813–9. doi:10.1093/hmg/9.5.813. PMID10749989.CS1 maint: Explicit use of et al. (link)
Elanko N, Sibbring JS, Metcalfe KA et al. (2002). "A survey of TWIST for mutations in craniosynostosis reveals a variable length polyglycine tract in asymptomatic individuals.". Hum. Mutat.18 (6): 535–41. doi:10.1002/humu.1230. PMID11748846.CS1 maint: Explicit use of et al. (link)